1. Home
  2. MRVI vs GROY Comparison

MRVI vs GROY Comparison

Compare MRVI & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • GROY
  • Stock Information
  • Founded
  • MRVI 2014
  • GROY 2020
  • Country
  • MRVI United States
  • GROY Canada
  • Employees
  • MRVI N/A
  • GROY N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • GROY
  • Sector
  • MRVI Health Care
  • GROY
  • Exchange
  • MRVI Nasdaq
  • GROY Nasdaq
  • Market Cap
  • MRVI 371.8M
  • GROY 322.2M
  • IPO Year
  • MRVI 2020
  • GROY 2021
  • Fundamental
  • Price
  • MRVI $2.42
  • GROY $3.62
  • Analyst Decision
  • MRVI Hold
  • GROY Strong Buy
  • Analyst Count
  • MRVI 10
  • GROY 4
  • Target Price
  • MRVI $5.84
  • GROY $4.58
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • GROY 2.5M
  • Earning Date
  • MRVI 08-11-2025
  • GROY 08-06-2025
  • Dividend Yield
  • MRVI N/A
  • GROY N/A
  • EPS Growth
  • MRVI N/A
  • GROY N/A
  • EPS
  • MRVI N/A
  • GROY N/A
  • Revenue
  • MRVI $219,830,000.00
  • GROY $12,376,000.00
  • Revenue This Year
  • MRVI N/A
  • GROY $82.74
  • Revenue Next Year
  • MRVI $7.23
  • GROY $51.73
  • P/E Ratio
  • MRVI N/A
  • GROY N/A
  • Revenue Growth
  • MRVI N/A
  • GROY 90.37
  • 52 Week Low
  • MRVI $1.67
  • GROY $1.16
  • 52 Week High
  • MRVI $9.60
  • GROY $3.65
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • GROY 65.91
  • Support Level
  • MRVI $2.28
  • GROY $2.89
  • Resistance Level
  • MRVI $2.47
  • GROY $3.37
  • Average True Range (ATR)
  • MRVI 0.14
  • GROY 0.15
  • MACD
  • MRVI -0.01
  • GROY 0.01
  • Stochastic Oscillator
  • MRVI 27.45
  • GROY 85.59

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.

Share on Social Networks: